GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT

Osteoporosis (OP) is a serious problem to patients who have long taken glucocorticoids. In the past two decade, much knowledge has been accumulated about the epidemiology of the disease and drugs with proven efficacy for its prevention and treatment have emerged. However, a large number of studies s...

Full description

Bibliographic Details
Main Author: Irina Aleksandrovna Baranova
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2010-06-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/295
_version_ 1797876900906926080
author Irina Aleksandrovna Baranova
author_facet Irina Aleksandrovna Baranova
author_sort Irina Aleksandrovna Baranova
collection DOAJ
description Osteoporosis (OP) is a serious problem to patients who have long taken glucocorticoids. In the past two decade, much knowledge has been accumulated about the epidemiology of the disease and drugs with proven efficacy for its prevention and treatment have emerged. However, a large number of studies suggest that there is a serious shortage in care to patients with glucocorticoid-induced OP, which calls for effective measures to bring the real level of its prevention and treatment in compliance with the current clinical guidelines
first_indexed 2024-04-10T02:08:44Z
format Article
id doaj.art-5391cc080226425fa3fda7b3f5d57fd8
institution Directory Open Access Journal
issn 1996-7012
2310-158X
language Russian
last_indexed 2024-04-10T02:08:44Z
publishDate 2010-06-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj.art-5391cc080226425fa3fda7b3f5d57fd82023-03-13T08:39:21ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2010-06-0142949910.14412/1996-7012-2010-6101600GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENTIrina Aleksandrovna BaranovaOsteoporosis (OP) is a serious problem to patients who have long taken glucocorticoids. In the past two decade, much knowledge has been accumulated about the epidemiology of the disease and drugs with proven efficacy for its prevention and treatment have emerged. However, a large number of studies suggest that there is a serious shortage in care to patients with glucocorticoid-induced OP, which calls for effective measures to bring the real level of its prevention and treatment in compliance with the current clinical guidelineshttps://mrj.ima-press.net/mrj/article/view/295глюкокортикоидный остеопорозпрофилактикалечение
spellingShingle Irina Aleksandrovna Baranova
GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
Современная ревматология
глюкокортикоидный остеопороз
профилактика
лечение
title GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
title_full GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
title_fullStr GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
title_full_unstemmed GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
title_short GLUCOCORTICOID-INDUCED OSTEOPOROSIS: PATHOGENESIS, PREVENTION, TREATMENT
title_sort glucocorticoid induced osteoporosis pathogenesis prevention treatment
topic глюкокортикоидный остеопороз
профилактика
лечение
url https://mrj.ima-press.net/mrj/article/view/295
work_keys_str_mv AT irinaaleksandrovnabaranova glucocorticoidinducedosteoporosispathogenesispreventiontreatment